A cluster randomized trial of routine HIV-1 viral load monitoring in Zambia: study design, implementation, and baseline cohort characteristics.
The benefit of routine HIV-1 viral load (VL) monitoring of patients on antiretroviral therapy (ART) in resource-constrained settings is uncertain because of the high costs associated with the test and the limited treatment options. We designed a cluster randomized controlled trial to compare the use...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-03-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2837376?pdf=render |
id |
doaj-892dbe4148114cf48a5337129038c0b4 |
---|---|
record_format |
Article |
spelling |
doaj-892dbe4148114cf48a5337129038c0b42020-11-25T01:51:49ZengPublic Library of Science (PLoS)PLoS ONE1932-62032010-03-0153e968010.1371/journal.pone.0009680A cluster randomized trial of routine HIV-1 viral load monitoring in Zambia: study design, implementation, and baseline cohort characteristics.John R KoetheAndrew O WestfallDora K LuhangaGina M ClarkJason D GoldmanPriscilla L MulengaRonald A CantrellBenjamin H ChiIsaac ZuluMichael S SaagJeffrey S A StringerThe benefit of routine HIV-1 viral load (VL) monitoring of patients on antiretroviral therapy (ART) in resource-constrained settings is uncertain because of the high costs associated with the test and the limited treatment options. We designed a cluster randomized controlled trial to compare the use of routine VL testing at ART-initiation and at 3, 6, 12, and 18 months, versus our local standard of care (which uses immunological and clinical criteria to diagnose treatment failure, with discretionary VL testing when the two do not agree).Dedicated study personnel were integrated into public-sector ART clinics. We collected participant information in a dedicated research database. Twelve ART clinics in Lusaka, Zambia constituted the units of randomization. Study clinics were stratified into pairs according to matching criteria (historical mortality rate, size, and duration of operation) to limit the effect of clustering, and independently randomized to the intervention and control arms. The study was powered to detect a 36% reduction in mortality at 18 months.From December 2006 to May 2008, we completed enrollment of 1973 participants. Measured baseline characteristics did not differ significantly between the study arms. Enrollment was staggered by clinic pair and truncated at two matched sites.A large clinical trial of routing VL monitoring was successfully implemented in a dynamic and rapidly growing national ART program. Close collaboration with local health authorities and adequate reserve staff were critical to success. Randomized controlled trials such as this will likely prove valuable in determining long-term outcomes in resource-constrained settings.Clinicaltrials.gov NCT00929604.http://europepmc.org/articles/PMC2837376?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
John R Koethe Andrew O Westfall Dora K Luhanga Gina M Clark Jason D Goldman Priscilla L Mulenga Ronald A Cantrell Benjamin H Chi Isaac Zulu Michael S Saag Jeffrey S A Stringer |
spellingShingle |
John R Koethe Andrew O Westfall Dora K Luhanga Gina M Clark Jason D Goldman Priscilla L Mulenga Ronald A Cantrell Benjamin H Chi Isaac Zulu Michael S Saag Jeffrey S A Stringer A cluster randomized trial of routine HIV-1 viral load monitoring in Zambia: study design, implementation, and baseline cohort characteristics. PLoS ONE |
author_facet |
John R Koethe Andrew O Westfall Dora K Luhanga Gina M Clark Jason D Goldman Priscilla L Mulenga Ronald A Cantrell Benjamin H Chi Isaac Zulu Michael S Saag Jeffrey S A Stringer |
author_sort |
John R Koethe |
title |
A cluster randomized trial of routine HIV-1 viral load monitoring in Zambia: study design, implementation, and baseline cohort characteristics. |
title_short |
A cluster randomized trial of routine HIV-1 viral load monitoring in Zambia: study design, implementation, and baseline cohort characteristics. |
title_full |
A cluster randomized trial of routine HIV-1 viral load monitoring in Zambia: study design, implementation, and baseline cohort characteristics. |
title_fullStr |
A cluster randomized trial of routine HIV-1 viral load monitoring in Zambia: study design, implementation, and baseline cohort characteristics. |
title_full_unstemmed |
A cluster randomized trial of routine HIV-1 viral load monitoring in Zambia: study design, implementation, and baseline cohort characteristics. |
title_sort |
cluster randomized trial of routine hiv-1 viral load monitoring in zambia: study design, implementation, and baseline cohort characteristics. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2010-03-01 |
description |
The benefit of routine HIV-1 viral load (VL) monitoring of patients on antiretroviral therapy (ART) in resource-constrained settings is uncertain because of the high costs associated with the test and the limited treatment options. We designed a cluster randomized controlled trial to compare the use of routine VL testing at ART-initiation and at 3, 6, 12, and 18 months, versus our local standard of care (which uses immunological and clinical criteria to diagnose treatment failure, with discretionary VL testing when the two do not agree).Dedicated study personnel were integrated into public-sector ART clinics. We collected participant information in a dedicated research database. Twelve ART clinics in Lusaka, Zambia constituted the units of randomization. Study clinics were stratified into pairs according to matching criteria (historical mortality rate, size, and duration of operation) to limit the effect of clustering, and independently randomized to the intervention and control arms. The study was powered to detect a 36% reduction in mortality at 18 months.From December 2006 to May 2008, we completed enrollment of 1973 participants. Measured baseline characteristics did not differ significantly between the study arms. Enrollment was staggered by clinic pair and truncated at two matched sites.A large clinical trial of routing VL monitoring was successfully implemented in a dynamic and rapidly growing national ART program. Close collaboration with local health authorities and adequate reserve staff were critical to success. Randomized controlled trials such as this will likely prove valuable in determining long-term outcomes in resource-constrained settings.Clinicaltrials.gov NCT00929604. |
url |
http://europepmc.org/articles/PMC2837376?pdf=render |
work_keys_str_mv |
AT johnrkoethe aclusterrandomizedtrialofroutinehiv1viralloadmonitoringinzambiastudydesignimplementationandbaselinecohortcharacteristics AT andrewowestfall aclusterrandomizedtrialofroutinehiv1viralloadmonitoringinzambiastudydesignimplementationandbaselinecohortcharacteristics AT dorakluhanga aclusterrandomizedtrialofroutinehiv1viralloadmonitoringinzambiastudydesignimplementationandbaselinecohortcharacteristics AT ginamclark aclusterrandomizedtrialofroutinehiv1viralloadmonitoringinzambiastudydesignimplementationandbaselinecohortcharacteristics AT jasondgoldman aclusterrandomizedtrialofroutinehiv1viralloadmonitoringinzambiastudydesignimplementationandbaselinecohortcharacteristics AT priscillalmulenga aclusterrandomizedtrialofroutinehiv1viralloadmonitoringinzambiastudydesignimplementationandbaselinecohortcharacteristics AT ronaldacantrell aclusterrandomizedtrialofroutinehiv1viralloadmonitoringinzambiastudydesignimplementationandbaselinecohortcharacteristics AT benjaminhchi aclusterrandomizedtrialofroutinehiv1viralloadmonitoringinzambiastudydesignimplementationandbaselinecohortcharacteristics AT isaaczulu aclusterrandomizedtrialofroutinehiv1viralloadmonitoringinzambiastudydesignimplementationandbaselinecohortcharacteristics AT michaelssaag aclusterrandomizedtrialofroutinehiv1viralloadmonitoringinzambiastudydesignimplementationandbaselinecohortcharacteristics AT jeffreysastringer aclusterrandomizedtrialofroutinehiv1viralloadmonitoringinzambiastudydesignimplementationandbaselinecohortcharacteristics AT johnrkoethe clusterrandomizedtrialofroutinehiv1viralloadmonitoringinzambiastudydesignimplementationandbaselinecohortcharacteristics AT andrewowestfall clusterrandomizedtrialofroutinehiv1viralloadmonitoringinzambiastudydesignimplementationandbaselinecohortcharacteristics AT dorakluhanga clusterrandomizedtrialofroutinehiv1viralloadmonitoringinzambiastudydesignimplementationandbaselinecohortcharacteristics AT ginamclark clusterrandomizedtrialofroutinehiv1viralloadmonitoringinzambiastudydesignimplementationandbaselinecohortcharacteristics AT jasondgoldman clusterrandomizedtrialofroutinehiv1viralloadmonitoringinzambiastudydesignimplementationandbaselinecohortcharacteristics AT priscillalmulenga clusterrandomizedtrialofroutinehiv1viralloadmonitoringinzambiastudydesignimplementationandbaselinecohortcharacteristics AT ronaldacantrell clusterrandomizedtrialofroutinehiv1viralloadmonitoringinzambiastudydesignimplementationandbaselinecohortcharacteristics AT benjaminhchi clusterrandomizedtrialofroutinehiv1viralloadmonitoringinzambiastudydesignimplementationandbaselinecohortcharacteristics AT isaaczulu clusterrandomizedtrialofroutinehiv1viralloadmonitoringinzambiastudydesignimplementationandbaselinecohortcharacteristics AT michaelssaag clusterrandomizedtrialofroutinehiv1viralloadmonitoringinzambiastudydesignimplementationandbaselinecohortcharacteristics AT jeffreysastringer clusterrandomizedtrialofroutinehiv1viralloadmonitoringinzambiastudydesignimplementationandbaselinecohortcharacteristics |
_version_ |
1724996150828728320 |